Gene therapy for longevity and targeted disease treatment.
Gene therapy has the power to extend healthy longevity and treat a litany of organ-specific conditions.
The eye is one outstanding candidate.
Luxturna received FDA approval in 2017. It targets a rare form of retinal dystrophy caused by RPE65 mutations.
Leave a reply